What is facial plethora?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Facial Plethora

Facial plethora is a clinical sign characterized by increased redness or ruddy appearance of the face caused by elevated blood volume or blood flow in the cutaneous vasculature.

Definition and Physiological Basis

Facial plethora represents a visible manifestation of increased cutaneous blood volume fraction in the facial region, particularly affecting the cheeks and central face 1. This ancient clinical sign, described since antiquity, was historically linked to increased blood volume or flow in the 19th century, though the precise physiological mechanism was only recently confirmed using modern near-infrared multispectral imaging technology 1.

Clinical Presentation

The appearance consists of a persistent ruddy, reddish, or flushed complexion affecting predominantly the face, distinguishing it from transient flushing episodes 2, 3.

Key distinguishing features include:

  • Location: Exclusively or very predominantly affects the facial region, particularly the cheeks 2, 3
  • Persistence: Unlike episodic flushing, plethora represents a sustained change in facial coloration 2
  • Underlying mechanism: Results from chronically increased blood volume fraction in facial cutaneous vessels rather than temporary vasodilation 1

Clinical Significance and Associated Conditions

Facial plethora serves as an important diagnostic clue for Cushing's syndrome and represents one of the earliest described clinical features of hypercortisolism 1.

Primary Association: Cushing's Syndrome

  • In patients with Cushing's syndrome, facial plethora correlates directly with disease activity and cortisol levels 1
  • Successful surgical treatment results in measurable decrease in facial blood volume fraction (from 17.7% to 15.8% on average) within approximately 5 days post-operatively 1
  • The change in blood volume fraction correlates significantly with postoperative cortisol levels (rs = 0.58; P = .0003), making resolution of plethora an early marker of biochemical cure 1
  • Patients with persistent Cushing's syndrome show increased blood volume fraction (18.5% to 21.4%) rather than the expected decrease 1

Differential Diagnosis

When evaluating facial plethora, consider:

  • Endocrine causes: Cushing's syndrome (most important), carcinoid syndrome, pheochromocytoma, medullary thyroid carcinoma, pancreatic cell tumors 2, 4
  • Hematologic conditions: Polycythemia vera (increased red blood cell mass)
  • Systemic diseases: Mastocytosis (including telangiectasia macularis eruptiva perstans), anaphylaxis 2, 5
  • Cardiovascular disease: Cardiac conditions affecting venous return 2

Diagnostic Approach

Base diagnosis on the date and mode of appearance, characteristics of the erythema, functional signs, and associated systemic manifestations 2, 3.

Essential Clinical Assessment

  • Onset and duration: Distinguish persistent plethora from episodic flushing 2
  • Distribution pattern: Confirm predominant facial involvement 3
  • Associated features: Screen for cushingoid features (central obesity, striae, proximal muscle weakness, hypertension, glucose intolerance) when Cushing's syndrome is suspected 1
  • Systemic symptoms: Evaluate for diarrhea (carcinoid), hypertension with paroxysmal symptoms (pheochromocytoma), or pruritus with urticaria (mastocytosis) 2, 5

Laboratory and Imaging Studies

For suspected Cushing's syndrome with facial plethora:

  • Obtain 24-hour urinary free cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression test 1
  • Consider near-infrared multispectral imaging where available to quantify blood volume fraction objectively 1

Common Pitfalls

  • Do not confuse facial plethora with transient flushing: Plethora is persistent, while flushing is episodic and triggered by specific factors 2, 4
  • Do not dismiss as benign rosacea without systemic evaluation: While rosacea commonly causes facial erythema, persistent plethora warrants endocrine investigation, particularly for Cushing's syndrome 2
  • Do not overlook subtle cushingoid features: Facial plethora may be an early sign before full syndrome manifestation 1

References

2
Research

Red face revisited: Flushing.

Clinics in dermatology, 2014

3
Research

[Differential diagnosis of red faces].

Annales de dermatologie et de venereologie, 2011

4
Research

Pathophysiological causes and clinical significance of flushing.

British journal of hospital medicine, 1993

Related Questions

What is the treatment for erythema of the face?
What is the cause of a patient's red face and how should it be evaluated and treated, considering potential underlying conditions such as rosacea, allergic reactions, or cardiovascular disease?
What could be causing my facial flushing, particularly in the cheeks, after working 7-10 hour shifts with an average of 12,000 steps per day?
What causes facial flushing and tingling of the cheeks and nose when lying down?
What causes flushed skin?
What are the clinical differences between Stevens‑Johnson syndrome and toxic epidermal necrolysis and how should each be managed?
In an asymptomatic patient with subclinical hypothyroidism (TSH 4.67 mIU/L, normal free T4) who is currently on levothyroxine, should I adjust the levothyroxine dose or simply monitor and repeat labs?
In an older postmenopausal woman on long‑term proton‑pump inhibitor therapy, how should I manage her increased osteoporosis risk and can she be switched to an H₂‑receptor antagonist?
What is the recommended pre‑operative management of hypothyroidism to obtain surgical clearance, including target thyroid function tests, levothyroxine (LT4) dosing, timing before elective surgery, and rapid‑acting strategies for urgent procedures?
How does Epstein-Barr virus infection occur?
What are the differential diagnoses for hemoptysis in an 84‑year‑old woman with a thoracic aortic aneurysm, pulmonary tuberculosis, and bronchiectasis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question